Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulated use of the water circuit disinfection device on a Mycobacterium chimaera-contaminated LivaNova 3T Heater Cooler Device: results of mycobacterial and bacterial surveillance.

The Journal of hospital infection·2025
Same author

Trends in surveillance indicators for central-catheter-associated bloodstream infections in a tertiary hospital in Switzerland.

The Journal of hospital infection·2024
Same author

The development of a nurse-led preoperative anaesthesia screening tool by Delphi consensus.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Extreme eutrophication and salinisation in the Coorong estuarine-lagoon ecosystem of Australia's largest river basin (Murray-Darling).

Marine pollution bulletin·2023
Same author

Mid-term quality of life after gastric band removal and single-stage conversion to gastric bypass: a single-center cohort study.

Langenbeck's archives of surgery·2022
Same author

The terminal lakes of the Murray River, Australia, were predominantly fresh before large-scale upstream water abstraction: Evidence from sedimentary diatoms and hydrodynamical modelling.

The Science of the total environment·2022
Same journal

Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

Clinical pharmacology and therapeutics·2026
Same journal

Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

Clinical pharmacology and therapeutics·2026
Same journal

Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

Clinical pharmacology and therapeutics·2026
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Model-based meta-analysis for comparative efficacy and safety: application in drug development and beyond.

J W Mandema1, M Gibbs, R A Boyd

  • 1Quantitative Solutions, Inc., Menlo Park, California, USA. jmandema@wequantify.com

Clinical Pharmacology and Therapeutics
|November 18, 2011
PubMed
Summary
This summary is machine-generated.

Model-based meta-analysis (MBMA) offers a quantitative approach to assess drug safety and efficacy. This method aids in efficient drug development by integrating data for comparative analysis, despite its limitations.

Related Experiment Videos

Last Updated: May 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Pharmacoeconomics
  • Drug Development
  • Biostatistics

Background:

  • High drug development costs and intense market competition necessitate efficient processes.
  • New drugs must demonstrate safety, efficacy, and cost-effectiveness against existing treatments.
  • Current drug development faces challenges in success rates and cost containment.

Purpose of the Study:

  • To discuss the application of model-based meta-analysis (MBMA) in drug development.
  • To highlight the utility of MBMA in comparative efficacy and safety assessments.
  • To outline the limitations of MBMA within the drug development context.

Main Methods:

  • MBMA integrates summary-level efficacy and safety data.
  • Provides a quantitative framework for comparative assessment.
  • Utilizes statistical modeling for data synthesis.

Main Results:

  • MBMA facilitates the integration of diverse data sources.
  • Enables quantitative comparison of drug candidates.
  • Offers insights into safety and efficacy profiles.

Conclusions:

  • MBMB serves as a valuable tool in drug development decision-making.
  • Its application can enhance the efficiency of bringing new therapies to market.
  • Understanding MBMA's limitations is crucial for its effective implementation.